Near Term Catalysts
- Conversion of pre-clinical programs into full scale collaborations
- Oral Insulin:
- Improved formulations
- Additional clinical studies
- Partnership with Big Pharma
- Agreement with FDA on heparin registration plan
- Completed formulation work
- Commercial potential demonstrated
- Strong market need with open competitive landscape